Dow Up 0.15% Nasdaq Up 0.21%

Nymox Pharmaceutical Corporation (NYMX)

-NasdaqCM
4.76 Up 0.02(0.42%) Sep 17, 3:59PM EDT
Prev Close:4.74
Open:4.74
Bid:3.77 x 1000
Ask:N/A
1y Target Est:9.84
Beta:0.47
Next Earnings Date:N/A
Day's Range:4.63 - 4.78
52wk Range:4.40 - 7.90
Volume:25,532
Avg Vol (3m):71,323
Market Cap:168.51M
P/E (ttm):N/A
EPS (ttm):-0.19
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NYMX

Comparison

Symbol% ChgMkt Cap
NYMXUp 0.42%168.51M
ABTUp 1.12%65.23B
LHDown 0.83%9.01B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):53.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.20
Quarterly EPS Est (Mar-14) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nymox Pharmaceutical Corporation, a biopharmaceutical company, is engaged in the research and development of products for the aging population. It provides NicAlert and TobacAlert products that use urine or saliva to detect use of and exposure to ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback